Colinz Q2 revenue rises 25%, profit rises 35%, but operating cash flow turns negative
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board approved the quarter and half-year results for 30 September 2026. Quarter revenue rose 24.9% to Rs 155.00 lakh from Rs 124.09 lakh, while profit rose 35.2% to Rs 18.65 lakh from Rs 13.79 lakh. For the half year, revenue fell 5.5% to Rs 279.09 lakh and profit slipped 3.4% to Rs 13.80 lakh. Net cash used in operating activities was Rs 131.81 lakh, versus Rs 166.19 lakh generated last year. The auditor's review found no material misstatement.
Quarterly earnings momentum is positive, but negative operating cash flow and weaker half-year numbers may weigh on sentiment and increase attention on cash management.